SCHEMBL7345919

SCHEMBL7345919

COc1cc(C)cc2nc[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.42
MMP12 P39900 1/20 0.40
SRC P12931 1/20 0.39
PARP1 P09874 2/20 0.39
CHEK1 O14757 1/20 0.39
PIM1 P11309 1/20 0.39
RPS6KA3 P51812 1/20 0.39
ABL1 P00519 1/20 0.38
RAD52 P43351 1/20 0.38
RIN1 Q13671 1/20 0.38
BRD4 O60885 1/20 0.38
PDPK1 O15530 1/20 0.37
LCK P06239 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
QPCT Q16769 2/20 0.35
BRAF P15056 2/20 0.34
IDO1 P14902 2/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34474974 0.80 NQO2 (0.42) MMP12SRCCHEK1PIM1ABL1
SCHEMBL27180959 0.80 NQO2 (0.42) MMP12SRCCHEK1PIM1ABL1
SCHEMBL8404371 0.76 PARP1 (0.43) MMP12PARP1CHEK1PIM1RPS6KA3
SCHEMBL18033648 0.75 CA12 (0.50) BRD4QPCT
Hydrochloric Acid SCHEMBL31004036 0.74 LMNA (0.49) SRCBRD4MAPTSMN1; SMN2QPCT
Bromide SCHEMBL31066901 0.74 CA12 (0.49) BRD4QPCT
SCHEMBL29209464 0.74 BPTF (0.47) BRD4MAPTSMN1; SMN2QPCT
SCHEMBL18033647 0.74 KDM4E (0.44) BRD4MAPTQPCT
SCHEMBL29579493 0.74 BPTF (0.47) BRD4MAPTSMN1; SMN2QPCT
SCHEMBL20125038 0.73 PARP1 (0.41) PARP1CHEK1PIM1RPS6KA3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed